A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand (2014)
Abstract Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a p ...Read more